Similar medications and substitutes for risankizumab
In short: Skyrizi (risankizumab) belongs to the IL-23 Inhibitors class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Skyrizi is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Skyrizi in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.